Despite considerable research efforts, tuberculosis (TB) remains a staggering burden on global health with 10.4 million new cases and 1.7 million deaths in 2016.
It is estimated that 2 billion individuals are infected with tuberculosis.
Centenary’s Tuberculosis Research Program in collaboration with the University of Sydney has recently been published in Plos One journal for their ongoing research into tuberculosis vaccine development and delivery. See the paper here
The Centenary Institute has hosted the TB-CRE 2021 Symposium, which has showcased the latest TB research from members and collaborators.
Dr Jessamy Tiffen, Head of the Centenary Institute’s ‘Melanoma Epigenetics Laboratory’, has received a $447,000 project grant from Cancer Council NSW.
A project involving the Centenary Institute has received MRFF funding to continue work on a unique, single-shot vaccine against COVID-19.